Reltecimod

Reltecimod
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T26367-25mg 25 mg -

7 - 10 business days*

1,491.00€
 
Description: Reltecimod, a CD28 antigen inhibitor, is used potentially for the treatment of... more
Product information "Reltecimod"
Description: Reltecimod, a CD28 antigen inhibitor, is used potentially for the treatment of necrotizing soft tissue infection. Smiles: C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](CC1=CC=C(O)C=C1)C(N[C@H](C(N[C@@H](C(O)=O)C)=O)CC(O)=O)=O)=O)C)=O)C(C)C)=O)CC(C)C)=O)CCSC)(=O)[C@H]2N(C([C@@H](NC([C@@H](C)N)=O)CO)=O)CCC2. References: Ahn M, Han YH, Park JE, Kim S, Lee WC, Lee SJ, Gunasekaran P, Cheong C, Shin SY Sr, Kim HY, Ryu EK, Murugan RN, Kim NH, Bang JK. A new class of peptidomimetics targeting the polo-box domain of Polo-like kinase 1. J Med Chem. 2015 Jan 8,58(1):294-304. doi: 10.1021/jm501147g. Epub 2014 Nov 5. PubMed PMID: 25347203.
Keywords: NSC-37096, P2TA, AB-103, P-2TA, AB103
Supplier: TargetMol
Supplier-Nr: T26367

Properties

Application: Targets CD28 antigen (CD28)
Conjugate: No
MW: 1037.19 D
Formula: C46H72N10O15S

Database Information

CAS : 1447799-33-8| Matching products
KEGG ID : K06470 | Matching products

Handling & Safety

Storage: +4°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Reltecimod"
Write a review
or to review a product.
Viewed